Update shared on 02 Dec 2025
Fair value Increased 6.08%Analysts have raised their price target for China Life Insurance from ¥26.94 to ¥28.58. They cite updates to their valuation model and reflect confidence in the company’s long-term outlook.
What's in the News
- China Life Insurance provided earnings guidance for the first nine months of 2025. The company estimates net profit attributable to equity holders will rise 50% to 70% year-on-year, reaching RMB156,785 million to RMB177,689 million (Key Developments).
- The company’s board will meet on October 30, 2025 to review and approve unaudited results for the nine months ended September 30, 2025 (Key Developments).
- The company announced an interim dividend of RMB 0.238 per share (HKD 0.26024 per share) for the first half of 2025, with payment expected on November 21, 2025 (Key Developments).
- At the annual general meeting on September 25, 2025, shareholders approved amendments to the company’s Articles of Association (Key Developments).
Valuation Changes
- Fair Value: increased from ¥26.94 to ¥28.58. This reflects a modest upward revision in analysts' intrinsic valuation.
- Discount Rate: remains unchanged at 7.02%. This indicates a consistent approach to risk and capital costs.
- Revenue Growth: minimal change, holding steady at approximately 28.00% year-on-year.
- Net Profit Margin: edged down slightly from 7.60% to 7.58%.
- Future P/E: increased from 14.39x to 15.21x. This suggests stronger future growth expectations are now being priced into the stock.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.